Review explores how the proteasome system influences immunity and its implications for disease pathogenesis.
The 26S proteasome degradation system is a central regulator of protein homeostasis and immune function, integrating antigen processing, inflammatory signaling, and cell fate decisions. Dysregulation of this system has profound consequences for immune tolerance, immune evasion, and immune-mediated pathology. In this review, we examine the roles of the constitutive 26S proteasome and the inducible immunoproteasome in shaping cellular immunological characteristics, with a particular focus on mesenchymal stem cells (MSCs) and cancer cells, two cell types that exhibit context-dependent immune privilege. We discuss how proteasome dynamics regulate antigen presentation, cytokine production, and the expression of immune checkpoint and immunomodulatory molecules under physiological and stress conditions such as hypoxia and metabolic imbalance. In addition, we summarize evidence linking altered proteasome function to the pathogenesis of autoimmune, immunodeficiency, and auto-inflammatory diseases. Collectively, the data reviewed highlight the proteasome system as a pivotal molecular hub controlling immune visibility and immune escape. Understanding how distinct proteasome isoforms operate in different microenvironments will be essential for developing targeted immunomodulatory and proteasome-based therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Abu-El-Rub et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: